IL-17A Expression in HIV-specific CD8 T Cells is Regulated by IL-4/IL-13 Following HIV-1 Prime-boost Immunization
Overview
Affiliations
Although Th1 and Th2 cytokines can inhibit interleukin (IL)-17-secreting T cells, how these cells are regulated under different infectious conditions is still debated. Our previous studies have shown that vaccination of IL-4 and IL-13 gene knockout (KO) mice can induce high-avidity HIV K(d)Gag197-205-specific CD8 T cells with better protective efficacy. In this study, when IL-13, IL-4, STAT6 KO, and wild-type BALB/c mice were prime-boost immunized with an HIV poxviral modality, elevated numbers of IL-17A(+) splenic K(d)Gag197-205-specific CD8 T cells were observed in all the KO mice compared with the wt BALB/c control. Similarly, when wt BALB/c mice were immunized with IL-13Rα2-adjuvanted HIV vaccines (that transiently inhibited IL-13 activity and induced high-avidity CD8 T cells with enhanced protective efficacy), elevated IL-17A(+) K(d)Gag197-205-specific CD8 T cells were detected both in the lung and the spleen. However, at the transcriptional level, elevated TGF-β, IL-6, ROR-γt, and IL-17A mRNA copy numbers were mainly detected in IL-4 KO, but not the IL-13 KO mice. These data suggested that TGF-β, IL-6, ROR-γt, but not IL-23a, played a role in IL-17A regulation in K(d)Gag197-205-specific CD8 T cells. Collectively, our findings suggest that IL-4 and IL-13 differentially regulate the expression of IL-17A in K(d)Gag197-205-specific CD8 T cells at the transcriptional and translational level, respectively, implicating IL-17A as an indirect modulator of CD8 T cell avidity and protective immunity.
Li Z, Jackson R, Ranasinghe C Vaccine X. 2019; 2:100035.
PMID: 31384749 PMC: 6668243. DOI: 10.1016/j.jvacx.2019.100035.
Khanna M, Jackson R, Alcantara S, Amarasena T, Li Z, Kelleher A Sci Rep. 2019; 9(1):5661.
PMID: 30952887 PMC: 6450945. DOI: 10.1038/s41598-019-41506-5.
Li Z, Jackson R, Ranasinghe C NPJ Vaccines. 2018; 3:10.
PMID: 29560282 PMC: 5847557. DOI: 10.1038/s41541-018-0048-6.
Townsend D, Trivedi S, Jackson R, Ranasinghe C J Gen Virol. 2017; 98(3):496-505.
PMID: 28056224 PMC: 5797952. DOI: 10.1099/jgv.0.000702.
Loxton A, Knaul J, Grode L, Gutschmidt A, Meller C, Eisele B Clin Vaccine Immunol. 2016; 24(2).
PMID: 27974398 PMC: 5299117. DOI: 10.1128/CVI.00439-16.